IRIS Accounts Production v23.3.0.418 06899460 director 1.4.22 31.3.23 31.3.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068994602022-03-31068994602023-03-31068994602022-04-012023-03-31068994602021-03-31068994602021-04-012022-03-31068994602022-03-3106899460ns10:Originalns15:EnglandWales2022-04-012023-03-3106899460ns14:PoundSterlingns10:Original2022-04-012023-03-3106899460ns10:Originalns10:Director12022-04-012023-03-3106899460ns10:Original2022-04-012023-03-3106899460ns10:Original2023-03-3106899460ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3106899460ns10:Originalns10:SmallEntities2022-04-012023-03-3106899460ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3106899460ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3106899460ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3106899460ns10:Originalns10:FullAccounts2022-04-012023-03-3106899460ns10:Original12022-04-012023-03-3106899460ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3106899460ns10:Originalns10:RegisteredOffice2022-04-012023-03-3106899460ns10:Original2022-03-3106899460ns10:Originalns5:CurrentFinancialInstruments2023-03-3106899460ns10:Originalns5:CurrentFinancialInstruments2022-03-3106899460ns10:Originalns5:Non-currentFinancialInstruments2023-03-3106899460ns10:Originalns5:Non-currentFinancialInstruments2022-03-3106899460ns5:ShareCapitalns10:Original2023-03-3106899460ns5:ShareCapitalns10:Original2022-03-3106899460ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3106899460ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3106899460ns10:Originalns5:NetGoodwill2022-04-012023-03-3106899460ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3106899460ns10:Originalns5:FurnitureFittings2022-04-012023-03-3106899460ns10:Originalns5:ComputerEquipment2022-04-012023-03-3106899460ns10:Original2021-04-012022-03-3106899460ns10:Originalns5:NetGoodwill2022-03-3106899460ns10:Originalns5:NetGoodwill2023-03-3106899460ns10:Originalns5:NetGoodwill2022-03-3106899460ns10:Originalns5:FurnitureFittings2022-03-3106899460ns10:Originalns5:ComputerEquipment2022-03-3106899460ns10:Original2022-03-3106899460ns10:Originalns5:FurnitureFittings2023-03-3106899460ns10:Originalns5:ComputerEquipment2023-03-3106899460ns10:Originalns5:FurnitureFittings2022-03-3106899460ns10:Originalns5:ComputerEquipment2022-03-3106899460ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106899460ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3106899460ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 06899460 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

CLINIC 95 LIMITED

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CLINIC 95 LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTOR: M J Hardman





REGISTERED OFFICE: 2 Manor Farm Court
Old Wolverton Road
Old Wolverton
Milton Keynes
Buckinghamshire
MK12 5NN





REGISTERED NUMBER: 06899460 (England and Wales)





ACCOUNTANTS: Ad Valorem Accountancy Services Limited
Chartered Certified Accountants
2 Manor Farm Court
Old Wolverton Road
Old Wolverton
Buckinghamshire
MK12 5NN

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 243,057 266,390
Tangible assets 5 168,892 209,046
411,949 475,436

CURRENT ASSETS
Stocks 9,279 8,947
Debtors 6 183,537 157,070
Cash at bank and in hand 135,622 178,416
328,438 344,433
CREDITORS
Amounts falling due within one year 7 179,702 186,511
NET CURRENT ASSETS 148,736 157,922
TOTAL ASSETS LESS CURRENT
LIABILITIES

560,685

633,358

CREDITORS
Amounts falling due after more than one
year

8

429,995

505,989
NET ASSETS 130,690 127,369

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 130,590 127,269
SHAREHOLDERS' FUNDS 130,690 127,369

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

BALANCE SHEET - continued
31 MARCH 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 November 2023 and were signed by:





M J Hardman - Director


CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023


1. STATUTORY INFORMATION

Clinic 95 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is recognised as the fair value of consideration received or receivable from dental activities.

GOODWILL
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is fifteen years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on cost
Computer equipment - 25% on cost

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 102 Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


2. ACCOUNTING POLICIES - continued

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2022 - 8 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 350,000
AMORTISATION
At 1 April 2022 83,610
Amortisation for year 23,333
At 31 March 2023 106,943
NET BOOK VALUE
At 31 March 2023 243,057
At 31 March 2022 266,390

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2022 340,285 5,309 345,594
Additions 8,820 4,547 13,367
At 31 March 2023 349,105 9,856 358,961
DEPRECIATION
At 1 April 2022 135,606 942 136,548
Charge for year 52,090 1,431 53,521
At 31 March 2023 187,696 2,373 190,069
NET BOOK VALUE
At 31 March 2023 161,409 7,483 168,892
At 31 March 2022 204,679 4,367 209,046

CLINIC 95 LIMITED (REGISTERED NUMBER: 06899460)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 14,469 15,674
Amounts owed by group undertakings 168,009 138,508
Other debtors 1,059 2,888
183,537 157,070

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 33,690 33,690
Hire purchase contracts 24,909 23,675
Trade creditors 58,768 65,330
Taxation and social security 37,926 41,212
Other creditors 24,409 22,604
179,702 186,511

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 368,940 402,672
Hire purchase contracts 46,099 71,110
Other creditors 14,956 32,207
429,995 505,989

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary 1 100 100